Gland Pharma  said it has raised Rs 1,943.86 crore from 70 anchor investors ahead of its initial public offering (IPO)  that opens on November 11, 2020. The company has raised funds at the upper end of the price band at Rs 1,500 per share by allotting 12,959,089 shares to investors. Overseas investors including SmallCap World Fund INC, Government of Singapore, The Nomura Trust And Banking Co and Goldman Sachs together grabbed nearly 20 per cent of the total anchor allotment. Domestic mutual fund houses, including Axis Mutual Fund, SBI Mutual Fund, Aditya Birla Sun Life Mutual Fund, ICICI Prudential Mutual Fund, Nippon India Mutual Fund and Kotak Mutual Fund cornered over 15 per cent of shares

(Economic Times)